Towards new tools for refined management of patients with advanced hepatocellular carcinoma under systemic therapy: some enthusiasm with a word of caution.
Division of Internal Medicine, Department of Medical and Surgical Sciences - DIMEC, University of Bologna, Bologna, Italy. Electronic address: fabio.piscaglia@unibo.it.
Fabio
F
Piscaglia
Alessandro
A
Cucchetti
Christoph F
CF
Dietrich
Veronica
V
Salvatore
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000000981:diagnostic imaging* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000000981:diagnostic imaging* / Q000188:drug therapy*; D008297:Male; D009536:Niacinamide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010671:Phenylurea Compounds / Q000627:therapeutic use*; D000077157:Sorafenib; D014463:Ultrasonography
D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D010671:Phenylurea Compounds; D009536:Niacinamide; D000077157:Sorafenib
CEUS; Contrast Enhanced Ultrasound; GIST; HCC; gastrointestinal stromal tumor; hepatocellular carcinoma